Finance

Lists
SIGA:NASDAQ
SIGA Technologies Inc
$3.02
-3.97%
(-0.12) 1D
Sep 15, 9:45:47 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SIGA...
Open
$3.14
High
$3.14
Low
$3.00
Mkt. cap
217.35M
Avg. vol.
681.76K
Volume
16.35K
52-wk high
$9.45
52-wk low
$2.83
EPS
-$0.04
Beta
0.96
Shares outstanding
71.85M
No. of employees
49
Open
$3.14
High
$3.14
Low
$3.00
Mkt. cap
217.35M
Avg. vol.
681.76K
Volume
16.35K
52-wk high
$9.45
52-wk low
$2.83
EPS
-$0.04
Beta
0.96
Shares outstanding
71.85M
No. of employees
49
Profile
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Wikipedia
About SIGA Technologies Inc
CEODiem Nguyen
Employees49
FoundedDec 28, 1995
Headquarters-
SectorPharmaceutical industry
Websitesiga.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.62M
3.79M
6.24M
41.00M
Cost of goods sold
8.06M
8.03M
6.89M
21.95M
Cost of revenue
8.06M
8.03M
6.89M
21.95M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.79M
5.26M
4.67M
5.15M
Operating expense
4.79M
5.26M
4.67M
5.15M
Total operating expenses
12.84M
13.29M
11.56M
27.10M
Operating income
-10.22M
-9.50M
-5.32M
13.91M
Other non operating income
-
-
-
-
EBT including unusual items
-8.36M
-7.96M
-4.04M
14.85M
EBT excluding unusual items
-8.36M
-7.96M
-4.04M
14.85M
Income tax expense
-1.99M
-2.53M
-589.43K
2.39M
Effective tax rate
23.82%
31.82%
14.58%
16.09%
Other operating expenses
-
-
-
-
Net income
-6.37M
-5.43M
-3.45M
12.46M
Net profit margin
-242.97%
-143.12%
-55.33%
30.40%
Earnings per share
-
-
-
-
Interest and investment income
1.87M
1.54M
1.28M
946.90K
Interest expense
-
-
-
-
Net interest expenses
1.87M
1.54M
1.28M
946.90K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.08M
-9.35M
-5.17M
14.06M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps